Beyond the Prescription: The Impacts of Unsupervised Drug Use

Self-medication, defined as the use of pharmacological agents without professional consultation, has moved from a marginal health behavior to a dominant mode of treatment across much of the world. Pooled data across sixty-nine studies and more than forty-one thousand participants place global self-medication prevalence at 67%, and the figure climbs to 70.1% among university students specifically. Antibiotic self-medication follows a similar pattern, affecting an estimated 43.0% of adults worldwide and peaking at 55.2% in sub-Saharan Africa. This review traces the biological consequences of that behavior along three axes: the direct toxicological damage that common analgesics inflict on the liver and kidneys, the evolutionary pressure that unsupervised antibiotic use places on bacterial populations, and the diagnostic delays created when self-treatment conceals the early signs of serious illness. The paper closes by arguing that patient education and expanded pharmacist oversight, rather than prohibition or enforcement, represent the more realistic route toward reducing the burden that unsupervised drug use places on individuals and health systems alike. Keywords: Self-medication; Hepatotoxicity; NAPQI; Antimicrobial resistance; Polypharmacy; Public health literacy